Ablation of supraventricular tachycardia in elderly persons presents a challenging problem to electrophysiologists. Friable cardiac structures, prone to catheter perforation, comorbid cardiovascular ...

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

A recent study published in Pacing and Clinical Electrophysiology (PACE) determined that the use of catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients. This ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...

The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...

The electrophysiologic mechanism may be due to either enhanced automaticity or triggered activity. In contrast to the paroxysmal variety, the nonparoxysmal type develops gradually and disappears ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.